Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Appl Immunohistochem Mol Morphol. 2012 Oct;20(5):451–453. doi: 10.1097/PAI.0b013e31824bb404

TABLE 1.

Positive Cases With PAX-2, PAX-8, and hKIM-1 Antibodies in Germ Cell Tumors

Germ Cell Tumor hKIM-1 PAX-2 PAX-8
Choriocarcinoma 0/1 (0%) 0/1 (0%) 0/1 (0%)
Embryonal carcinoma 10/21 (48%) 0/21 (0%) 0/21 (0%)
Intratubular germ cell neoplasia 0/2 (0%) 0/2 (0%) 0/2 (0%)
Seminoma 0/62 (0%) 0/62 (0%) 0/62 (0%)
Spermatocytic seminoma 0/1 (0%) 0/1 (0%) 0/1 (0%)
Teratoma 0/5 (0%) 0/5 (0%) 0/5 (0%)
Yolk sac tumor 4/8 (50%) 4/8 (50%) 2/8 (25%)
Total 14/100 (14%) 4/100 (4%) 2/100 (2%)